EP 3996674 A1 20220518 - COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR
Title (en)
COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR
Title (de)
ZUSAMMENSETZUNG MIT MINDESTENS EINEM OXAZOLIN ZUR HEMMUNG DES WACHSTUMS VON MALASSEZIA-HEFEN, INSBESONDERE BEI MILCHSCHORF
Title (fr)
COMPOSITION COMPRENANT AU MOINS UNE OXAZOLINE POUR INHIBER LA CROISSANCE DE LEVURE DU GENRE MALASSEZIA IMPLIQUÉE NOTAMMENT DANS LES CROÛTES DE LAIT
Publication
Application
Priority
- FR 1907861 A 20190712
- EP 2020069799 W 20200713
Abstract (en)
[origin: WO2021009142A1] The present invention relates to a composition comprising at least one oxazoline, such as OΧ100, which inhibits the growth of Malassezia yeast and/or prevents and/or treats ailments caused by Malassezia yeast, seborrhoeic dermatitis, cradle cap, Malassezia folliculitis, dandruff, pityriasis versicolor or pityriasis capitis. The present invention also relates to a composition comprising at least one oxazoline such as OΧ100, at least one compound such as malic acid diester and an oleodistillate of vegetable oil and/or arabinogalactan, and to its use in preventing and/or treating, in particular, ailments caused by Malassezia yeast, seborrhoeic dermatitis, cradle cap, Malassezia folliculitis, dandruff, pityriasis versicolor or pityriasis capitis.
IPC 8 full level
A61K 9/00 (2006.01); A61K 8/37 (2006.01); A61K 8/49 (2006.01); A61K 8/73 (2006.01); A61K 9/06 (2006.01); A61K 31/22 (2006.01); A61K 31/421 (2006.01); A61K 31/715 (2006.01); A61K 45/06 (2006.01); A61K 47/14 (2017.01); A61K 47/44 (2017.01); A61P 31/10 (2006.01); A61Q 17/00 (2006.01)
CPC (source: EP US)
A61K 8/37 (2013.01 - EP); A61K 8/49 (2013.01 - EP US); A61K 8/63 (2013.01 - EP); A61K 8/678 (2013.01 - EP); A61K 8/73 (2013.01 - EP); A61K 8/922 (2013.01 - EP); A61K 9/0014 (2013.01 - EP); A61K 9/06 (2013.01 - EP); A61K 31/22 (2013.01 - EP); A61K 31/421 (2013.01 - EP US); A61K 31/715 (2013.01 - EP); A61K 47/14 (2013.01 - EP US); A61K 47/36 (2013.01 - US); A61K 47/44 (2013.01 - EP US); A61P 31/10 (2017.12 - EP US); A61Q 5/006 (2013.01 - EP US); A61Q 17/005 (2013.01 - US); A61Q 19/005 (2013.01 - EP); A61K 2300/00 (2013.01 - EP); A61Q 17/005 (2013.01 - EP)
Citation (search report)
See references of WO 2021009142A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
FR 3098394 A1 20210115; FR 3098394 B1 20220708; EP 3996674 A1 20220518; US 2022249446 A1 20220811; WO 2021009142 A1 20210121
DOCDB simple family (application)
FR 1907861 A 20190712; EP 2020069799 W 20200713; EP 20737053 A 20200713; US 202017624692 A 20200713